approval
saveDALBAVANCIN HYDROCHLORIDE — FDA approval
October 23, 2025updated 4mo ago
community read0 votes
Sponsor: TEVA PHARMS INC. Form: POWDER. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalSTIMUFEND: STIMUFEND (PEGFILGRASTIM-FPGK) — FDA approvalOct 21, 2025
- approvalGLYCOPYRROLATE — FDA approvalOct 27, 2025
- approvalCONEXXENCE: CONEXXENCE (DENOSUMAB-BNHT) — FDA approvalOct 29, 2025
- device recallFresenius Kabi USA, LLC device recall (Cls II)Nov 3, 2025
- device recallFresenius Kabi USA, LLC device recall (Cls I)Nov 3, 2025
- approvalDALBAVANCIN HYDROCHLORIDE: DALBAVANCIN HYDROCHLORIDE — FDA approvalNov 10, 2025
🐶 often sniffed alongside
top 8- tagApproval258 co-mentions · 129 sources
- drugRNS-60236 co-mentions · 149 sources
- drugDIPRIVAN78 co-mentions · 39 sources
- drugPROPOFOL39 co-mentions · 39 sources
- drugDILAUDID-HP38 co-mentions · 19 sources
- tagRecall33 co-mentions · 20 sources
- drughydromorphone hydrochloride ER19 co-mentions · 19 sources
- drugHYDROMORPHONE HYDROCHLORIDE19 co-mentions · 19 sources
comments(0)
5-min edit window · permanent after that